Therapeutic responses in patients with advanced NSCLC enrolled in early-phase clinical trials at MD Anderson

Abstract We evaluated clinical outcomes and safety profiles in patients with non-small cell lung cancer (NSCLC) treated in early-phase trials. A retrospective review of 546 NSCLC cases treated from January 2016 to December 2024 at The University of Texas MD Anderson Cancer Center was performed using...

Deskribapen osoa

Xehetasun bibliografikoak

Egile Nagusiak:	Jeong Uk Lim, Heather Y. Lin, Lei Kang, Hung Le, Tin-Yun Tang, Stephane Champiat, Ecaterina Elena Dumbrava, Xiuning Le, Aung Naing, Sarina A. Piha-Paul, Jordi Rodon Ahnert, Apostolia Maria Tsimberidou, Timothy A. Yap, Siqing Fu, Funda Meric-Bernstam, David S. Hong
Formatua:	Artigo
Hizkuntza:	Inglês
Argitaratua:	Nature Portfolio 2026-01-01
Saila:	npj Precision Oncology
Sarrera elektronikoa:	https://doi.org/10.1038/s41698-025-01261-5
Etiketak:	Etiketa erantsi Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!